Heart failure study using AI messages to improve treatment
Part of Heart & circulation clinical trials.
This study tests whether messages from a large language model (a type of AI) can help doctors prescribe the right medicines for heart failure. It may help people with heart failure get the best guideline-recommended treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a scheduled appointment with a heart doctor at a participating clinic.
- You have been diagnosed with heart failure in the last 2 years.
- Your heart failure diagnosis is confirmed by either using a water pill (loop diuretic), a recent heart ultrasound showing low pumping strength, or a note from your heart doctor describing heart failure signs or symptoms.
- You do NOT have severely low blood pressure, very slow heart rate, advanced kidney disease, certain heart muscle diseases, a heart transplant or a heart pump, severe valve problems, or a congenital heart disease appointment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether patients with severe heart failure follow their prescribed medications as recommended by treatment guidelines. The researchers want to understand what helps or prevents patients from taking their medicines correctly, which could improve their heart function and symptoms.
This study tests whether sending guidance messages to your cardiologist improves how heart failure care is provided. It may help patients get the right medication plan, if they are not already on the strongest versions of the standard treatments.
This study tests whether a wearable device that monitors your heart and transmits data to your doctor can help optimize your heart failure medications after hospitalization. The goal is to prevent future hospital visits and improve your health by keeping closer tabs on how your body responds to treatment adjustments.
This trial tests a smartphone-based program (HeartMed-HF) to see if it can help people with heart failure after a recent heart attack exercise more and feel better. If you join, you'll use a digital tool to guide your recovery.
This study looks at how “personalized” (precision) treatment planning for heart failure may work, using results from heart imaging (echocardiogram) or a blood test called B-type natriuretic peptide. You may join if you have heart failure and can follow frequent study check-ins.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.